1 Study Coverage
    1.1 Anti-obesity Drugs Product Introduction
    1.2 Market by Type
        1.2.1 Global Anti-obesity Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028
        1.2.2 Peripherally Acting Anti-obesity Drugs
        1.2.3 Centrally Acting Anti-obesity Drugs
    1.3 Market by Application
        1.3.1 Global Anti-obesity Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028
        1.3.2 Kids
        1.3.3 Adults
    1.4 Study Objectives
    1.5 Years Considered
2 Executive Summary
    2.1 Global Anti-obesity Drugs Sales Estimates and Forecasts 2017-2028
    2.2 Global Anti-obesity Drugs Revenue Estimates and Forecasts 2017-2028
    2.3 Global Anti-obesity Drugs Revenue by Region: 2017 VS 2021 VS 2028
    2.4 Global Anti-obesity Drugs Sales by Region
        2.4.1 Global Anti-obesity Drugs Sales by Region (2017-2022)
        2.4.2 Global Sales Anti-obesity Drugs by Region (2023-2028)
    2.5 Global Anti-obesity Drugs Revenue by Region
        2.5.1 Global Anti-obesity Drugs Revenue by Region (2017-2022)
        2.5.2 Global Anti-obesity Drugs Revenue by Region (2023-2028)
    2.6 North America
    2.7 Europe
    2.8 Asia-Pacific
    2.9 Latin America
    2.10 Middle East & Africa
3 Competition by Manufacturers
    3.1 Global Anti-obesity Drugs Sales by Manufacturers
        3.1.1 Global Top Anti-obesity Drugs Manufacturers by Sales (2017-2022)
        3.1.2 Global Anti-obesity Drugs Sales Market Share by Manufacturers (2017-2022)
        3.1.3 Global Top 10 and Top 5 Largest Manufacturers of Anti-obesity Drugs in 2021
    3.2 Global Anti-obesity Drugs Revenue by Manufacturers
        3.2.1 Global Anti-obesity Drugs Revenue by Manufacturers (2017-2022)
        3.2.2 Global Anti-obesity Drugs Revenue Market Share by Manufacturers (2017-2022)
        3.2.3 Global Top 10 and Top 5 Companies by Anti-obesity Drugs Revenue in 2021
    3.3 Global Anti-obesity Drugs Sales Price by Manufacturers (2017-2022)
    3.4 Analysis of Competitive Landscape
        3.4.1 Manufacturers Market Concentration Ratio (CR5 and HHI)
        3.4.2 Global Anti-obesity Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3)
        3.4.3 Global Anti-obesity Drugs Manufacturers Geographical Distribution
    3.5 Mergers & Acquisitions, Expansion Plans
4 Market Size by Type
    4.1 Global Anti-obesity Drugs Sales by Type
        4.1.1 Global Anti-obesity Drugs Historical Sales by Type (2017-2022)
        4.1.2 Global Anti-obesity Drugs Forecasted Sales by Type (2023-2028)
        4.1.3 Global Anti-obesity Drugs Sales Market Share by Type (2017-2028)
    4.2 Global Anti-obesity Drugs Revenue by Type
        4.2.1 Global Anti-obesity Drugs Historical Revenue by Type (2017-2022)
        4.2.2 Global Anti-obesity Drugs Forecasted Revenue by Type (2023-2028)
        4.2.3 Global Anti-obesity Drugs Revenue Market Share by Type (2017-2028)
    4.3 Global Anti-obesity Drugs Price by Type
        4.3.1 Global Anti-obesity Drugs Price by Type (2017-2022)
        4.3.2 Global Anti-obesity Drugs Price Forecast by Type (2023-2028)
5 Market Size by Application
    5.1 Global Anti-obesity Drugs Sales by Application
        5.1.1 Global Anti-obesity Drugs Historical Sales by Application (2017-2022)
        5.1.2 Global Anti-obesity Drugs Forecasted Sales by Application (2023-2028)
        5.1.3 Global Anti-obesity Drugs Sales Market Share by Application (2017-2028)
    5.2 Global Anti-obesity Drugs Revenue by Application
        5.2.1 Global Anti-obesity Drugs Historical Revenue by Application (2017-2022)
        5.2.2 Global Anti-obesity Drugs Forecasted Revenue by Application (2023-2028)
        5.2.3 Global Anti-obesity Drugs Revenue Market Share by Application (2017-2028)
    5.3 Global Anti-obesity Drugs Price by Application
        5.3.1 Global Anti-obesity Drugs Price by Application (2017-2022)
        5.3.2 Global Anti-obesity Drugs Price Forecast by Application (2023-2028)
6 North America
    6.1 North America Anti-obesity Drugs Market Size by Type
        6.1.1 North America Anti-obesity Drugs Sales by Type (2017-2028)
        6.1.2 North America Anti-obesity Drugs Revenue by Type (2017-2028)
    6.2 North America Anti-obesity Drugs Market Size by Application
        6.2.1 North America Anti-obesity Drugs Sales by Application (2017-2028)
        6.2.2 North America Anti-obesity Drugs Revenue by Application (2017-2028)
    6.3 North America Anti-obesity Drugs Market Size by Country
        6.3.1 North America Anti-obesity Drugs Sales by Country (2017-2028)
        6.3.2 North America Anti-obesity Drugs Revenue by Country (2017-2028)
        6.3.3 U.S.
        6.3.4 Canada
7 Europe
    7.1 Europe Anti-obesity Drugs Market Size by Type
        7.1.1 Europe Anti-obesity Drugs Sales by Type (2017-2028)
        7.1.2 Europe Anti-obesity Drugs Revenue by Type (2017-2028)
    7.2 Europe Anti-obesity Drugs Market Size by Application
        7.2.1 Europe Anti-obesity Drugs Sales by Application (2017-2028)
        7.2.2 Europe Anti-obesity Drugs Revenue by Application (2017-2028)
    7.3 Europe Anti-obesity Drugs Market Size by Country
        7.3.1 Europe Anti-obesity Drugs Sales by Country (2017-2028)
        7.3.2 Europe Anti-obesity Drugs Revenue by Country (2017-2028)
        7.3.3 Germany
        7.3.4 France
        7.3.5 U.K.
        7.3.6 Italy
        7.3.7 Russia
8 Asia Pacific
    8.1 Asia Pacific Anti-obesity Drugs Market Size by Type
        8.1.1 Asia Pacific Anti-obesity Drugs Sales by Type (2017-2028)
        8.1.2 Asia Pacific Anti-obesity Drugs Revenue by Type (2017-2028)
    8.2 Asia Pacific Anti-obesity Drugs Market Size by Application
        8.2.1 Asia Pacific Anti-obesity Drugs Sales by Application (2017-2028)
        8.2.2 Asia Pacific Anti-obesity Drugs Revenue by Application (2017-2028)
    8.3 Asia Pacific Anti-obesity Drugs Market Size by Region
        8.3.1 Asia Pacific Anti-obesity Drugs Sales by Region (2017-2028)
        8.3.2 Asia Pacific Anti-obesity Drugs Revenue by Region (2017-2028)
        8.3.3 China
        8.3.4 Japan
        8.3.5 South Korea
        8.3.6 India
        8.3.7 Australia
        8.3.8 Taiwan
        8.3.9 Indonesia
        8.3.10 Thailand
        8.3.11 Malaysia
        8.3.12 Philippines
9 Latin America
    9.1 Latin America Anti-obesity Drugs Market Size by Type
        9.1.1 Latin America Anti-obesity Drugs Sales by Type (2017-2028)
        9.1.2 Latin America Anti-obesity Drugs Revenue by Type (2017-2028)
    9.2 Latin America Anti-obesity Drugs Market Size by Application
        9.2.1 Latin America Anti-obesity Drugs Sales by Application (2017-2028)
        9.2.2 Latin America Anti-obesity Drugs Revenue by Application (2017-2028)
    9.3 Latin America Anti-obesity Drugs Market Size by Country
        9.3.1 Latin America Anti-obesity Drugs Sales by Country (2017-2028)
        9.3.2 Latin America Anti-obesity Drugs Revenue by Country (2017-2028)
        9.3.3 Mexico
        9.3.4 Brazil
        9.3.5 Argentina
10 Middle East and Africa
    10.1 Middle East and Africa Anti-obesity Drugs Market Size by Type
        10.1.1 Middle East and Africa Anti-obesity Drugs Sales by Type (2017-2028)
        10.1.2 Middle East and Africa Anti-obesity Drugs Revenue by Type (2017-2028)
    10.2 Middle East and Africa Anti-obesity Drugs Market Size by Application
        10.2.1 Middle East and Africa Anti-obesity Drugs Sales by Application (2017-2028)
        10.2.2 Middle East and Africa Anti-obesity Drugs Revenue by Application (2017-2028)
    10.3 Middle East and Africa Anti-obesity Drugs Market Size by Country
        10.3.1 Middle East and Africa Anti-obesity Drugs Sales by Country (2017-2028)
        10.3.2 Middle East and Africa Anti-obesity Drugs Revenue by Country (2017-2028)
        10.3.3 Turkey
        10.3.4 Saudi Arabia
11 Company Profiles
    11.1 Merck
        11.1.1 Merck Corporation Information
        11.1.2 Merck Overview
        11.1.3 Merck Anti-obesity Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.1.4 Merck Anti-obesity Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.1.5 Merck Recent Developments
    11.2 Novo Nordisk
        11.2.1 Novo Nordisk Corporation Information
        11.2.2 Novo Nordisk Overview
        11.2.3 Novo Nordisk Anti-obesity Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.2.4 Novo Nordisk Anti-obesity Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.2.5 Novo Nordisk Recent Developments
    11.3 Pfizer
        11.3.1 Pfizer Corporation Information
        11.3.2 Pfizer Overview
        11.3.3 Pfizer Anti-obesity Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.3.4 Pfizer Anti-obesity Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.3.5 Pfizer Recent Developments
    11.4 Arena Pharmaceuticals
        11.4.1 Arena Pharmaceuticals Corporation Information
        11.4.2 Arena Pharmaceuticals Overview
        11.4.3 Arena Pharmaceuticals Anti-obesity Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.4.4 Arena Pharmaceuticals Anti-obesity Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.4.5 Arena Pharmaceuticals Recent Developments
    11.5 Roche
        11.5.1 Roche Corporation Information
        11.5.2 Roche Overview
        11.5.3 Roche Anti-obesity Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.5.4 Roche Anti-obesity Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.5.5 Roche Recent Developments
    11.6 GlaxoSmithKline
        11.6.1 GlaxoSmithKline Corporation Information
        11.6.2 GlaxoSmithKline Overview
        11.6.3 GlaxoSmithKline Anti-obesity Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.6.4 GlaxoSmithKline Anti-obesity Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.6.5 GlaxoSmithKline Recent Developments
    11.7 Orexigen Therapeutics
        11.7.1 Orexigen Therapeutics Corporation Information
        11.7.2 Orexigen Therapeutics Overview
        11.7.3 Orexigen Therapeutics Anti-obesity Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.7.4 Orexigen Therapeutics Anti-obesity Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.7.5 Orexigen Therapeutics Recent Developments
    11.8 Vivus
        11.8.1 Vivus Corporation Information
        11.8.2 Vivus Overview
        11.8.3 Vivus Anti-obesity Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.8.4 Vivus Anti-obesity Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.8.5 Vivus Recent Developments
    11.9 Amylin
        11.9.1 Amylin Corporation Information
        11.9.2 Amylin Overview
        11.9.3 Amylin Anti-obesity Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.9.4 Amylin Anti-obesity Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.9.5 Amylin Recent Developments
    11.10 Alizyme
        11.10.1 Alizyme Corporation Information
        11.10.2 Alizyme Overview
        11.10.3 Alizyme Anti-obesity Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.10.4 Alizyme Anti-obesity Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.10.5 Alizyme Recent Developments
    11.11 Boehringer Ingelheim
        11.11.1 Boehringer Ingelheim Corporation Information
        11.11.2 Boehringer Ingelheim Overview
        11.11.3 Boehringer Ingelheim Anti-obesity Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.11.4 Boehringer Ingelheim Anti-obesity Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.11.5 Boehringer Ingelheim Recent Developments
    11.12 Eisai
        11.12.1 Eisai Corporation Information
        11.12.2 Eisai Overview
        11.12.3 Eisai Anti-obesity Drugs Sales, Price, Revenue and Gross Margin (2017-2022)
        11.12.4 Eisai Anti-obesity Drugs Product Model Numbers, Pictures, Descriptions and Specifications
        11.12.5 Eisai Recent Developments
12 Industry Chain and Sales Channels Analysis
    12.1 Anti-obesity Drugs Industry Chain Analysis
    12.2 Anti-obesity Drugs Key Raw Materials
        12.2.1 Key Raw Materials
        12.2.2 Raw Materials Key Suppliers
    12.3 Anti-obesity Drugs Production Mode & Process
    12.4 Anti-obesity Drugs Sales and Marketing
        12.4.1 Anti-obesity Drugs Sales Channels
        12.4.2 Anti-obesity Drugs Distributors
    12.5 Anti-obesity Drugs Customers
13 Market Drivers, Opportunities, Challenges and Risks Factors Analysis
    13.1 Anti-obesity Drugs Industry Trends
    13.2 Anti-obesity Drugs Market Drivers
    13.3 Anti-obesity Drugs Market Challenges
    13.4 Anti-obesity Drugs Market Restraints
14 Key Findings in The Global Anti-obesity Drugs Study
15 Appendix
    15.1 Research Methodology
        15.1.1 Methodology/Research Approach
        15.1.2 Data Source
    15.2 Author Details
    15.3 Disclaimer
                  
              

                

                 
List of Tables
    Table 1. Global Anti-obesity Drugs Market Size Growth Rate by Type, 2017 VS 2021 VS 2028 (US$ Million)
    Table 2. Major Manufacturers of Peripherally Acting Anti-obesity Drugs
    Table 3. Major Manufacturers of Centrally Acting Anti-obesity Drugs
    Table 4. Global Anti-obesity Drugs Market Size Growth Rate by Application, 2017 VS 2021 VS 2028 (US$ Million)
    Table 5. Global Anti-obesity Drugs Revenue by Region: 2017 VS 2021 VS 2028 (US$ Million)
    Table 6. Global Anti-obesity Drugs Sales by Region (2017-2022) & (K Units)
    Table 7. Global Anti-obesity Drugs Sales Market Share by Region (2017-2022)
    Table 8. Global Anti-obesity Drugs Sales by Region (2023-2028) & (K Units)
    Table 9. Global Anti-obesity Drugs Sales Market Share by Region (2023-2028)
    Table 10. Global Anti-obesity Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 11. Global Anti-obesity Drugs Revenue Market Share by Region (2017-2022)
    Table 12. Global Anti-obesity Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 13. Global Anti-obesity Drugs Revenue Market Share by Region (2023-2028)
    Table 14. Global Anti-obesity Drugs Sales by Manufacturers (2017-2022) & (K Units)
    Table 15. Global Anti-obesity Drugs Sales Share by Manufacturers (2017-2022)
    Table 16. Global Anti-obesity Drugs Revenue by Manufacturers (2017-2022) & (US$ Million)
    Table 17. Global Anti-obesity Drugs Revenue Share by Manufacturers (2017-2022)
    Table 18. Anti-obesity Drugs Price by Manufacturers (2017-2022) &(USD/Unit)
    Table 19. Global Anti-obesity Drugs Manufacturers Market Concentration Ratio (CR5 and HHI)
    Table 20. Global Anti-obesity Drugs by Company Type (Tier 1, Tier 2, and Tier 3) & (based on the Revenue in Anti-obesity Drugs as of 2021)
    Table 21. Anti-obesity Drugs Manufacturing Base Distribution and Headquarters
    Table 22. Manufacturers Anti-obesity Drugs Product Offered
    Table 23. Date of Manufacturers Enter into Anti-obesity Drugs Market
    Table 24. Mergers & Acquisitions, Expansion Plans
    Table 25. Global Anti-obesity Drugs Sales by Type (2017-2022) & (K Units)
    Table 26. Global Anti-obesity Drugs Sales by Type (2023-2028) & (K Units)
    Table 27. Global Anti-obesity Drugs Sales Share by Type (2017-2022)
    Table 28. Global Anti-obesity Drugs Sales Share by Type (2023-2028)
    Table 29. Global Anti-obesity Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 30. Global Anti-obesity Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 31. Global Anti-obesity Drugs Revenue Share by Type (2017-2022)
    Table 32. Global Anti-obesity Drugs Revenue Share by Type (2023-2028)
    Table 33. Anti-obesity Drugs Price by Type (2017-2022) & (USD/Unit)
    Table 34. Global Anti-obesity Drugs Price Forecast by Type (2023-2028) & (USD/Unit)
    Table 35. Global Anti-obesity Drugs Sales by Application (2017-2022) & (K Units)
    Table 36. Global Anti-obesity Drugs Sales by Application (2023-2028) & (K Units)
    Table 37. Global Anti-obesity Drugs Sales Share by Application (2017-2022)
    Table 38. Global Anti-obesity Drugs Sales Share by Application (2023-2028)
    Table 39. Global Anti-obesity Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 40. Global Anti-obesity Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 41. Global Anti-obesity Drugs Revenue Share by Application (2017-2022)
    Table 42. Global Anti-obesity Drugs Revenue Share by Application (2023-2028)
    Table 43. Anti-obesity Drugs Price by Application (2017-2022) & (USD/Unit)
    Table 44. Global Anti-obesity Drugs Price Forecast by Application (2023-2028) & (USD/Unit)
    Table 45. North America Anti-obesity Drugs Sales by Type (2017-2022) & (K Units)
    Table 46. North America Anti-obesity Drugs Sales by Type (2023-2028) & (K Units)
    Table 47. North America Anti-obesity Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 48. North America Anti-obesity Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 49. North America Anti-obesity Drugs Sales by Application (2017-2022) & (K Units)
    Table 50. North America Anti-obesity Drugs Sales by Application (2023-2028) & (K Units)
    Table 51. North America Anti-obesity Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 52. North America Anti-obesity Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 53. North America Anti-obesity Drugs Sales by Country (2017-2022) & (K Units)
    Table 54. North America Anti-obesity Drugs Sales by Country (2023-2028) & (K Units)
    Table 55. North America Anti-obesity Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 56. North America Anti-obesity Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 57. Europe Anti-obesity Drugs Sales by Type (2017-2022) & (K Units)
    Table 58. Europe Anti-obesity Drugs Sales by Type (2023-2028) & (K Units)
    Table 59. Europe Anti-obesity Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 60. Europe Anti-obesity Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 61. Europe Anti-obesity Drugs Sales by Application (2017-2022) & (K Units)
    Table 62. Europe Anti-obesity Drugs Sales by Application (2023-2028) & (K Units)
    Table 63. Europe Anti-obesity Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 64. Europe Anti-obesity Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 65. Europe Anti-obesity Drugs Sales by Country (2017-2022) & (K Units)
    Table 66. Europe Anti-obesity Drugs Sales by Country (2023-2028) & (K Units)
    Table 67. Europe Anti-obesity Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 68. Europe Anti-obesity Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 69. Asia Pacific Anti-obesity Drugs Sales by Type (2017-2022) & (K Units)
    Table 70. Asia Pacific Anti-obesity Drugs Sales by Type (2023-2028) & (K Units)
    Table 71. Asia Pacific Anti-obesity Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 72. Asia Pacific Anti-obesity Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 73. Asia Pacific Anti-obesity Drugs Sales by Application (2017-2022) & (K Units)
    Table 74. Asia Pacific Anti-obesity Drugs Sales by Application (2023-2028) & (K Units)
    Table 75. Asia Pacific Anti-obesity Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 76. Asia Pacific Anti-obesity Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 77. Asia Pacific Anti-obesity Drugs Sales by Region (2017-2022) & (K Units)
    Table 78. Asia Pacific Anti-obesity Drugs Sales by Region (2023-2028) & (K Units)
    Table 79. Asia Pacific Anti-obesity Drugs Revenue by Region (2017-2022) & (US$ Million)
    Table 80. Asia Pacific Anti-obesity Drugs Revenue by Region (2023-2028) & (US$ Million)
    Table 81. Latin America Anti-obesity Drugs Sales by Type (2017-2022) & (K Units)
    Table 82. Latin America Anti-obesity Drugs Sales by Type (2023-2028) & (K Units)
    Table 83. Latin America Anti-obesity Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 84. Latin America Anti-obesity Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 85. Latin America Anti-obesity Drugs Sales by Application (2017-2022) & (K Units)
    Table 86. Latin America Anti-obesity Drugs Sales by Application (2023-2028) & (K Units)
    Table 87. Latin America Anti-obesity Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 88. Latin America Anti-obesity Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 89. Latin America Anti-obesity Drugs Sales by Country (2017-2022) & (K Units)
    Table 90. Latin America Anti-obesity Drugs Sales by Country (2023-2028) & (K Units)
    Table 91. Latin America Anti-obesity Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 92. Latin America Anti-obesity Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 93. Middle East and Africa Anti-obesity Drugs Sales by Type (2017-2022) & (K Units)
    Table 94. Middle East and Africa Anti-obesity Drugs Sales by Type (2023-2028) & (K Units)
    Table 95. Middle East and Africa Anti-obesity Drugs Revenue by Type (2017-2022) & (US$ Million)
    Table 96. Middle East and Africa Anti-obesity Drugs Revenue by Type (2023-2028) & (US$ Million)
    Table 97. Middle East and Africa Anti-obesity Drugs Sales by Application (2017-2022) & (K Units)
    Table 98. Middle East and Africa Anti-obesity Drugs Sales by Application (2023-2028) & (K Units)
    Table 99. Middle East and Africa Anti-obesity Drugs Revenue by Application (2017-2022) & (US$ Million)
    Table 100. Middle East and Africa Anti-obesity Drugs Revenue by Application (2023-2028) & (US$ Million)
    Table 101. Middle East and Africa Anti-obesity Drugs Sales by Country (2017-2022) & (K Units)
    Table 102. Middle East and Africa Anti-obesity Drugs Sales by Country (2023-2028) & (K Units)
    Table 103. Middle East and Africa Anti-obesity Drugs Revenue by Country (2017-2022) & (US$ Million)
    Table 104. Middle East and Africa Anti-obesity Drugs Revenue by Country (2023-2028) & (US$ Million)
    Table 105. Merck Corporation Information
    Table 106. Merck Description and Major Businesses
    Table 107. Merck Anti-obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 108. Merck Anti-obesity Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 109. Merck Recent Developments
    Table 110. Novo Nordisk Corporation Information
    Table 111. Novo Nordisk Description and Major Businesses
    Table 112. Novo Nordisk Anti-obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 113. Novo Nordisk Anti-obesity Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 114. Novo Nordisk Recent Developments
    Table 115. Pfizer Corporation Information
    Table 116. Pfizer Description and Major Businesses
    Table 117. Pfizer Anti-obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 118. Pfizer Anti-obesity Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 119. Pfizer Recent Developments
    Table 120. Arena Pharmaceuticals Corporation Information
    Table 121. Arena Pharmaceuticals Description and Major Businesses
    Table 122. Arena Pharmaceuticals Anti-obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 123. Arena Pharmaceuticals Anti-obesity Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 124. Arena Pharmaceuticals Recent Developments
    Table 125. Roche Corporation Information
    Table 126. Roche Description and Major Businesses
    Table 127. Roche Anti-obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 128. Roche Anti-obesity Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 129. Roche Recent Developments
    Table 130. GlaxoSmithKline Corporation Information
    Table 131. GlaxoSmithKline Description and Major Businesses
    Table 132. GlaxoSmithKline Anti-obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 133. GlaxoSmithKline Anti-obesity Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 134. GlaxoSmithKline Recent Developments
    Table 135. Orexigen Therapeutics Corporation Information
    Table 136. Orexigen Therapeutics Description and Major Businesses
    Table 137. Orexigen Therapeutics Anti-obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 138. Orexigen Therapeutics Anti-obesity Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 139. Orexigen Therapeutics Recent Developments
    Table 140. Vivus Corporation Information
    Table 141. Vivus Description and Major Businesses
    Table 142. Vivus Anti-obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 143. Vivus Anti-obesity Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 144. Vivus Recent Developments
    Table 145. Amylin Corporation Information
    Table 146. Amylin Description and Major Businesses
    Table 147. Amylin Anti-obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 148. Amylin Anti-obesity Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 149. Amylin Recent Developments
    Table 150. Alizyme Corporation Information
    Table 151. Alizyme Description and Major Businesses
    Table 152. Alizyme Anti-obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 153. Alizyme Anti-obesity Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 154. Alizyme Recent Developments
    Table 155. Boehringer Ingelheim Corporation Information
    Table 156. Boehringer Ingelheim Description and Major Businesses
    Table 157. Boehringer Ingelheim Anti-obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 158. Boehringer Ingelheim Anti-obesity Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 159. Boehringer Ingelheim Recent Developments
    Table 160. Eisai Corporation Information
    Table 161. Eisai Description and Major Businesses
    Table 162. Eisai Anti-obesity Drugs Sales (K Units), Revenue (US$ Million), Price (USD/Unit) and Gross Margin (2017-2022)
    Table 163. Eisai Anti-obesity Drugs Product Model Numbers, Pictures, Descriptions and Specifications
    Table 164. Eisai Recent Developments
    Table 165. Key Raw Materials Lists
    Table 166. Raw Materials Key Suppliers Lists
    Table 167. Anti-obesity Drugs Distributors List
    Table 168. Anti-obesity Drugs Customers List
    Table 169. Anti-obesity Drugs Market Trends
    Table 170. Anti-obesity Drugs Market Drivers
    Table 171. Anti-obesity Drugs Market Challenges
    Table 172. Anti-obesity Drugs Market Restraints
    Table 173. Research Programs/Design for This Report
    Table 174. Key Data Information from Secondary Sources
    Table 175. Key Data Information from Primary Sources
List of Figures
    Figure 1. Anti-obesity Drugs Product Picture
    Figure 3. Global Anti-obesity Drugs Market Share by Type in 2021 & 2028
    Figure 3. Peripherally Acting Anti-obesity Drugs Product Picture
    Figure 4. Centrally Acting Anti-obesity Drugs Product Picture
    Figure 5. Global Anti-obesity Drugs Market Share by Application in 2021 & 2028
    Figure 6. Kids
    Figure 7. Adults
    Figure 8. Anti-obesity Drugs Report Years Considered
    Figure 9. Global Anti-obesity Drugs Sales 2017-2028 (K Units)
    Figure 10. Global Anti-obesity Drugs Revenue, (US$ Million), 2017 VS 2021 VS 2028
    Figure 11. Global Anti-obesity Drugs Revenue 2017-2028 (US$ Million)
    Figure 12. Global Anti-obesity Drugs Revenue Market Share by Region in Percentage: 2021 Versus 2028
    Figure 13. Global Anti-obesity Drugs Sales Market Share by Region (2017-2022)
    Figure 14. Global Anti-obesity Drugs Sales Market Share by Region (2023-2028)
    Figure 15. North America Anti-obesity Drugs Sales YoY (2017-2028) & (K Units)
    Figure 16. North America Anti-obesity Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 17. Europe Anti-obesity Drugs Sales YoY (2017-2028) & (K Units)
    Figure 18. Europe Anti-obesity Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 19. Asia-Pacific Anti-obesity Drugs Sales YoY (2017-2028) & (K Units)
    Figure 20. Asia-Pacific Anti-obesity Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 21. Latin America Anti-obesity Drugs Sales YoY (2017-2028) & (K Units)
    Figure 22. Latin America Anti-obesity Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 23. Middle East & Africa Anti-obesity Drugs Sales YoY (2017-2028) & (K Units)
    Figure 24. Middle East & Africa Anti-obesity Drugs Revenue YoY (2017-2028) & (US$ Million)
    Figure 25. The Anti-obesity Drugs Market Share of Top 10 and Top 5 Largest Manufacturers Around the World in 2021
    Figure 26. The Top 5 and 10 Largest Manufacturers of Anti-obesity Drugs in the World: Market Share by Anti-obesity Drugs Revenue in 2021
    Figure 27. Global Anti-obesity Drugs Market Share by Company Type (Tier 1, Tier 2, and Tier 3): 2017 VS 2021
    Figure 28. Global Anti-obesity Drugs Sales Market Share by Type (2017-2028)
    Figure 29. Global Anti-obesity Drugs Revenue Market Share by Type (2017-2028)
    Figure 30. Global Anti-obesity Drugs Sales Market Share by Application (2017-2028)
    Figure 31. Global Anti-obesity Drugs Revenue Market Share by Application (2017-2028)
    Figure 32. North America Anti-obesity Drugs Sales Market Share by Type (2017-2028)
    Figure 33. North America Anti-obesity Drugs Revenue Market Share by Type (2017-2028)
    Figure 34. North America Anti-obesity Drugs Sales Market Share by Application (2017-2028)
    Figure 35. North America Anti-obesity Drugs Revenue Market Share by Application (2017-2028)
    Figure 36. North America Anti-obesity Drugs Sales Share by Country (2017-2028)
    Figure 37. North America Anti-obesity Drugs Revenue Share by Country (2017-2028)
    Figure 38. U.S. Anti-obesity Drugs Revenue (2017-2028) & (US$ Million)
    Figure 39. Canada Anti-obesity Drugs Revenue (2017-2028) & (US$ Million)
    Figure 40. Europe Anti-obesity Drugs Sales Market Share by Type (2017-2028)
    Figure 41. Europe Anti-obesity Drugs Revenue Market Share by Type (2017-2028)
    Figure 42. Europe Anti-obesity Drugs Sales Market Share by Application (2017-2028)
    Figure 43. Europe Anti-obesity Drugs Revenue Market Share by Application (2017-2028)
    Figure 44. Europe Anti-obesity Drugs Sales Share by Country (2017-2028)
    Figure 45. Europe Anti-obesity Drugs Revenue Share by Country (2017-2028)
    Figure 46. Germany Anti-obesity Drugs Revenue (2017-2028) & (US$ Million)
    Figure 47. France Anti-obesity Drugs Revenue (2017-2028) & (US$ Million)
    Figure 48. U.K. Anti-obesity Drugs Revenue (2017-2028) & (US$ Million)
    Figure 49. Italy Anti-obesity Drugs Revenue (2017-2028) & (US$ Million)
    Figure 50. Russia Anti-obesity Drugs Revenue (2017-2028) & (US$ Million)
    Figure 51. Asia Pacific Anti-obesity Drugs Sales Market Share by Type (2017-2028)
    Figure 52. Asia Pacific Anti-obesity Drugs Revenue Market Share by Type (2017-2028)
    Figure 53. Asia Pacific Anti-obesity Drugs Sales Market Share by Application (2017-2028)
    Figure 54. Asia Pacific Anti-obesity Drugs Revenue Market Share by Application (2017-2028)
    Figure 55. Asia Pacific Anti-obesity Drugs Sales Share by Region (2017-2028)
    Figure 56. Asia Pacific Anti-obesity Drugs Revenue Share by Region (2017-2028)
    Figure 57. China Anti-obesity Drugs Revenue (2017-2028) & (US$ Million)
    Figure 58. Japan Anti-obesity Drugs Revenue (2017-2028) & (US$ Million)
    Figure 59. South Korea Anti-obesity Drugs Revenue (2017-2028) & (US$ Million)
    Figure 60. India Anti-obesity Drugs Revenue (2017-2028) & (US$ Million)
    Figure 61. Australia Anti-obesity Drugs Revenue (2017-2028) & (US$ Million)
    Figure 62. Taiwan Anti-obesity Drugs Revenue (2017-2028) & (US$ Million)
    Figure 63. Indonesia Anti-obesity Drugs Revenue (2017-2028) & (US$ Million)
    Figure 64. Thailand Anti-obesity Drugs Revenue (2017-2028) & (US$ Million)
    Figure 65. Malaysia Anti-obesity Drugs Revenue (2017-2028) & (US$ Million)
    Figure 66. Philippines Anti-obesity Drugs Revenue (2017-2028) & (US$ Million)
    Figure 67. Latin America Anti-obesity Drugs Sales Market Share by Type (2017-2028)
    Figure 68. Latin America Anti-obesity Drugs Revenue Market Share by Type (2017-2028)
    Figure 69. Latin America Anti-obesity Drugs Sales Market Share by Application (2017-2028)
    Figure 70. Latin America Anti-obesity Drugs Revenue Market Share by Application (2017-2028)
    Figure 71. Latin America Anti-obesity Drugs Sales Share by Country (2017-2028)
    Figure 72. Latin America Anti-obesity Drugs Revenue Share by Country (2017-2028)
    Figure 73. Mexico Anti-obesity Drugs Revenue (2017-2028) & (US$ Million)
    Figure 74. Brazil Anti-obesity Drugs Revenue (2017-2028) & (US$ Million)
    Figure 75. Argentina Anti-obesity Drugs Revenue (2017-2028) & (US$ Million)
    Figure 76. Middle East and Africa Anti-obesity Drugs Sales Market Share by Type (2017-2028)
    Figure 77. Middle East and Africa Anti-obesity Drugs Revenue Market Share by Type (2017-2028)
    Figure 78. Middle East and Africa Anti-obesity Drugs Sales Market Share by Application (2017-2028)
    Figure 79. Middle East and Africa Anti-obesity Drugs Revenue Market Share by Application (2017-2028)
    Figure 80. Middle East and Africa Anti-obesity Drugs Sales Share by Country (2017-2028)
    Figure 81. Middle East and Africa Anti-obesity Drugs Revenue Share by Country (2017-2028)
    Figure 82. Turkey Anti-obesity Drugs Revenue (2017-2028) & (US$ Million)
    Figure 83. Saudi Arabia Anti-obesity Drugs Revenue (2017-2028) & (US$ Million)
    Figure 84. U.A.E Anti-obesity Drugs Revenue (2017-2028) & (US$ Million)
    Figure 85. Anti-obesity Drugs Value Chain
    Figure 86. Anti-obesity Drugs Production Process
    Figure 87. Channels of Distribution
    Figure 88. Distributors Profiles
    Figure 89. Bottom-up and Top-down Approaches for This Report
    Figure 90. Data Triangulation
    Figure 91. Key Executives Interviewed